Individuals with type 2 diabetes who receive treatment with GLP-1 RAs do not have an increased risk for acute pancreatitis.

Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

In this population-based cohort study, patients with type 2 diabetes who received glucagon-like peptide-1 receptor agonists had a higher risk of developing gastroesophageal reflux disease and ...

A bottleneck in ensuring access to widespread molecular diagnostics, especially in low- and middle-income countries, has been ...